FDA Approves Over-the-Counter Nasacort Allergy 24HR to Treat Hay Fever and Nasal Allergies
October 11, 2013 -- The U.S. Food and Drug Administration today approved Nasacort Allergy 24HR (triamcinolone acetonide), a nasal spray for the nonprescription or over-the-counter (OTC) treatment of nasal allergy symptoms (nasal congestion, runny nose, sneezing, and itchy nose). Nasacort Allergy 24HR is labeled for use in children 2 years of age and older, adolescents, and adults.
Nasacort Allergy 24HR belongs to a class of drugs known as glucocorticoids. It is the first drug in this class to be made available OTC for treatment of the symptoms of nasal allergies.
Nasacort Allergy 24HR is a nasal spray and is indicated for use once daily. There are different dosing instructions for adults and children 12 years of age and older, children 6 to under 12 years of age, and children 2 to under 6 years of age. Nasacort Allergy 24HR should not be used in children under age 2. Additional information included in the labeling informs consumers that when using this product, the growth rate of some children might be slightly slower. The labeling also states that if a child needs to use the spray for longer than two months a year, the parent should talk to the child’s doctor.
Posted: October 2013